Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.38
+0.39 (6.51%)
Apr 16, 2026, 4:00 PM EDT - Market closed

Cartesian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
169188461112173403
Market Cap Growth
-47.73%-59.36%313.44%-35.45%-57.09%23.07%
Enterprise Value
56.6670.93260.02344.0574.65309.19
Last Close Price
6.387.2117.9120.6833.9097.80
PE Ratio
--1.44-3.99-0.42339.00-444.54
PS Ratio
60.4767.0511.864.291.564.74
PB Ratio
--1.49-67.85-0.251.8417.89
P/TBV Ratio
-1.32-1.48-45.70-6.8552.70496.49
P/FCF Ratio
--2.36-14.08-2.17-5.27-6.56
P/OCF Ratio
--2.54-19.49-2.18-5.47-6.67
EV/Sales Ratio
20.2625.366.6813.230.673.63
EV/EBITDA Ratio
--0.51-6.08-4.024.72-92.43
EV/EBIT Ratio
--0.49-5.92-3.985.14-67.26
EV/FCF Ratio
--0.89-7.94-6.70-2.27-5.03
Debt / Equity Ratio
0.010.010.02-0.060.391.52
Debt / EBITDA Ratio
-0.09-0.09-0.33-0.132.40-10.23
Debt / FCF Ratio
-0.16-0.16-0.43-0.21-1.15-0.56
Net Debt / Equity Ratio
0.890.8929.200.15-1.03-4.17
Net Debt / EBITDA Ratio
0.800.804.650.77-6.1128.05
Net Debt / FCF Ratio
1.421.426.061.282.951.53
Asset Turnover
0.010.010.110.110.680.52
Quick Ratio
8.458.459.291.265.761.91
Current Ratio
8.658.659.431.335.912.00
Return on Equity (ROE)
-18.87%-18.87%-28.38%959.08%60.82%-1137.85%
Return on Assets (ROA)
-36.63%-36.63%-11.91%-33.78%9.08%-7.47%
Return on Invested Capital (ROIC)
-72.30%-72.30%-21.01%-70.29%77.95%-61.93%
Return on Capital Employed (ROCE)
-41.36%-41.36%-13.53%-45.77%12.73%-5.36%
Earnings Yield
-77.04%-69.63%-25.07%-240.62%0.29%-0.22%
FCF Yield
-46.94%-42.34%-7.10%-46.02%-18.98%-15.25%
Buyback Yield / Dilution
-49.63%-49.63%88.10%0.00%-27.59%-3289.12%
Total Shareholder Return
-49.63%-49.63%88.10%0.00%-27.59%-3289.12%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q